Search | VHL Search Portal

1.

Natural course of metastatic castration-resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone-sensitive setting.

Gebrael, Georges; Hage Chehade, Chadi; Sayegh, Nicolas; Tripathi, Nishita; Chigarira, Beverly; Goel, Divyam; Nordblad, Blake; McFarland, Taylor R; Narang, Arshit; Srivastava, Ayana; Tandar, Clara; Dal, Emre; Jo, Yeonjung; Galarza Fortuna, Gliceida; Mathew Thomas, Vinay; Sahu, Kamal K; Li, Haoran; Maughan, Benjamin L; Swami, Umang; Agarwal, Neeraj.

Prostate ; 84(9): 888-892, 2024 Jun.

Article in English | MEDLINE | ID: mdl-38561317

2.

Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor.

Gebrael, Georges; Jo, Yeonjung; Mathew Thomas, Vinay; Li, Haoran; Sayegh, Nicolas; Tripathi, Nishita; Srivastava, Ayana; Nordblad, Blake; Dal, Emre; Narang, Arshit; Brundage, James; Campbell, Patrick; Galarza Fortuna, Gliceida; Hage Chehade, Chadi; Maughan, Benjamin L; Agarwal, Neeraj; Swami, Umang.

Cancer ; 2024 Apr 02.

Article in English | MEDLINE | ID: mdl-38564301

3.

A Phase II Study of Rucaparib Monotherapy in Nonmetastatic, Hormone-Sensitive Prostate Cancer Demonstrating "BRCAness" Genotype (ROAR).

Sahu, Kamal Kant; Li, Haoran; Mathew Thomas, Vinay; Benson, Mallory; Boucher, Ken; Gupta, Sumati; Kohli, Manish; Swami, Umang; Agarwal, Neeraj; Maughan, Benjamin L.

Oncologist ; 29(5): 450-e725, 2024 May 03.

Article in English | MEDLINE | ID: mdl-38452035

4.

Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trial.

Coletta, Adriana M; Simon, Lea Haverbeck; Maslana, Kelsey; Taylor, Sarah; Larson, Kish; Hansen, Pamela A; Thomas, Vinay Mathew; Ulrich, Cornelia M; Kohli, Manish; Chipman, Jonathan; Swami, Umang; Gupta, Sumati; Maughan, Benjamin L; Agarwal, Neeraj.

BMC Cancer ; 24(1): 493, 2024 Apr 18.

Article in English | MEDLINE | ID: mdl-38637770

5.

Impact of androgen receptor alterations on cell-free DNA genomic profiling on survival outcomes in metastatic castration-resistant prostate cancer.

Tripathi, Nishita; Thomas, Vinay Mathew; Sayegh, Nicolas; Gebrael, Georges; Chigarira, Beverly; Jo, Yeonjung; Li, Haoran; Sahu, Kamal K; Nussenzveig, Roberto; Nordblad, Blake; Swami, Umang; Agarwal, Neeraj; Maughan, Benjamin L.

Prostate ; 83(16): 1602-1609, 2023 12.

Article in English | MEDLINE | ID: mdl-37644774

6.

Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell Carcinoma.

Li, Haoran; Sahu, Kamal Kant; Brundage, James; Benson, Mallory; Swami, Umang; Boucher, Kenneth M; Gupta, Sumati; Hawks, Josiah; Sirohi, Deepika; Agarwal, Neeraj; Maughan, Benjamin L.

Oncologist ; 28(8): 737-e693, 2023 08 03.

Article in English | MEDLINE | ID: mdl-36952231

7.

The Role of Physician Specialty in the Underutilization of Standard-of-Care Treatment Intensification in Patients With Metastatic Castration-sensitive Prostate Cancer.

Swami, Umang; Hong, Agnes; El-Chaar, Nader N; Ramaswamy, Krishnan; Diessner, Brandon J; Blauer-Peterson, Cori J; Sandin, Rickard; Nimke, David; Agarwal, Neeraj.

J Urol ; 209(6): 1120-1131, 2023 06.

Article in English | MEDLINE | ID: mdl-36789668

8.

Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate Cancer.

Freeman, Meredith N; Jang, Albert; Zhu, Jason; Sanati, Farhad; Nandagopal, Lakshminarayanan; Ravindranathan, Deepak; Desai, Arpita; Phone, Audrey; Nussenzveig, Roberto; Jaeger, Ellen; Caputo, Sydney A; Koshkin, Vadim S; Swami, Umang; Basu, Arnab; Bilen, Mehmet A; Agarwal, Neeraj; Sartor, Oliver; Burgess, Earle F; Barata, Pedro C.

Oncologist ; 27(3): 220-227, 2022 03 11.

Article in English | MEDLINE | ID: mdl-35274720

9.

Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race.

Zimmerman, Raquel; Bilen, Mehmet A; Heath, Elisabeth I; Nandagopal, Lakshminarayanan; Swami, Umang; Kessel, Adam; Jaeger, Ellen; Wesolowski, Sergiusz; Hernanadez, Edgar J; Chipman, Jonathan; Mack, Alleda; Ravindranathan, Deepak; Maughan, Benjamin L; Nussenzveig, Roberto; Yandell, Mark; Kohli, Manish; Lilly, Michael B; Sartor, A Oliver; Agarwal, Neeraj; Barata, Pedro C.

Oncologist ; 27(10): e815-e818, 2022 10 01.

Article in English | MEDLINE | ID: mdl-36036607

10.

Radium-223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results.

Maughan, Benjamin L; Kessel, Adam; McFarland, Taylor Ryan; Sayegh, Nicolas; Nussenzveig, Roberto; Hahn, Andrew W; Hoffman, John M; Morton, Kathyrn; Sirohi, Deepika; Kohli, Manish; Swami, Umang; Boucher, Kenneth; Haaland, Benjamin; Agarwal, Neeraj.

Oncologist ; 26(12): 1006-e2129, 2021 12.

Article in English | MEDLINE | ID: mdl-34423501

11.

Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Platform.

Lin, Edwin; Hahn, Andrew W; Nussenzveig, Roberto H; Wesolowski, Sergiusz; Sayegh, Nicolas; Maughan, Benjamin L; McFarland, Taylor; Rathi, Nityam; Sirohi, Deepika; Sonpavde, Guru; Swami, Umang; Kohli, Manish; Rich, Thereasa; Sartor, Oliver; Yandell, Mark; Agarwal, Neeraj.

Oncologist ; 26(9): 751-760, 2021 09.

Article in English | MEDLINE | ID: mdl-34157173

12.

Comparative Effectiveness of Immune Checkpoint Inhibitors in Patients with Platinum Refractory Advanced Urothelial Carcinoma.

Swami, Umang; Haaland, Benjamin; Kessel, Adam; Nussenzveig, Roberto; Maughan, Benjamin Louis; Esther, John; Sirohi, Deepika; Pal, Sumanta K; Grivas, Petros; Agarwal, Neeraj.

J Urol ; 205(3): 709-717, 2021 03.

Article in English | MEDLINE | ID: mdl-33080152

13.

Landmark Series on Disparities in Surgical Oncology: Melanoma.

Asare, Elliot A; Swami, Umang; Stewart, John H.

Ann Surg Oncol ; 28(12): 6986-6993, 2021 Nov.

Article in English | MEDLINE | ID: mdl-34191178

14.

The Quest for an Ideal Neoadjuvant Systemic Therapy in Cisplatin-Ineligible Patients with Muscle-Invasive Localized Urothelial Carcinoma.

Swami, Umang; Grivas, Petros; Agarwal, Neeraj.

Oncologist ; 24(5): 580-583, 2019 05.

Article in English | MEDLINE | ID: mdl-30926675

15.

Ipilimumab-induced hypophysitis, a single academic center experience.

Snyders, Travis; Chakos, Daniel; Swami, Umang; Latour, Emile; Chen, Yiyi; Fleseriu, Maria; Milhem, Mohammed; Zakharia, Yousef; Zahr, Roula.

Pituitary ; 22(5): 488-496, 2019 Oct.

Article in English | MEDLINE | ID: mdl-31327112

16.

The Management of Metastatic Castrate-Sensitive Prostate Cancer: From Guidelines to Real-World Practice.

Gebrael, Georges; Thomas, Vinay Mathew; Swami, Umang; Agarwal, Neeraj.

Oncologist ; 28(9): 746-749, 2023 09 07.

Article in English | MEDLINE | ID: mdl-37014098

17.

Editorial Comment.

Sayegh, Nicolas; Swami, Umang.

J Urol ; 207(5): 1019, 2022 05.

Article in English | MEDLINE | ID: mdl-35143329

18.

Drug development in metastatic prostate cancer: lessons from ACIS.

Swami, Umang; Agarwal, Neeraj.

Lancet Oncol ; 22(11): 1487-1488, 2021 11.

Article in English | MEDLINE | ID: mdl-34600603

19.

Editorial Comment.

Swami, Umang; Agarwal, Neeraj.

J Urol ; 206(6): 1429, 2021 12.

Article in English | MEDLINE | ID: mdl-34455827

20.

Eribulin in Cancer Treatment.

Swami, Umang; Shah, Umang; Goel, Sanjay.

Mar Drugs ; 13(8): 5016-58, 2015 Aug 07.

Article in English | MEDLINE | ID: mdl-26262627

VHL Search Portal

Information and Knowledge for Health

Config filters

Your selection (0)

Export format:

Export:

Natural course of metastatic castration-resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone-sensitive setting.

Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor.

A Phase II Study of Rucaparib Monotherapy in Nonmetastatic, Hormone-Sensitive Prostate Cancer Demonstrating "BRCAness" Genotype (ROAR).

Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trial.

Impact of androgen receptor alterations on cell-free DNA genomic profiling on survival outcomes in metastatic castration-resistant prostate cancer.

Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell Carcinoma.

The Role of Physician Specialty in the Underutilization of Standard-of-Care Treatment Intensification in Patients With Metastatic Castration-sensitive Prostate Cancer.

Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate Cancer.

Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race.

Radium-223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results.

Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Platform.

Comparative Effectiveness of Immune Checkpoint Inhibitors in Patients with Platinum Refractory Advanced Urothelial Carcinoma.

Landmark Series on Disparities in Surgical Oncology: Melanoma.

The Quest for an Ideal Neoadjuvant Systemic Therapy in Cisplatin-Ineligible Patients with Muscle-Invasive Localized Urothelial Carcinoma.

Ipilimumab-induced hypophysitis, a single academic center experience.

The Management of Metastatic Castrate-Sensitive Prostate Cancer: From Guidelines to Real-World Practice.

Editorial Comment.

Drug development in metastatic prostate cancer: lessons from ACIS.

Editorial Comment.

Eribulin in Cancer Treatment.